Adam Charles Watts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adam Charles Watts has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Zaid Hamoodi
Upper Limb Unit, Wrightington Hospital, Wigan and Leigh Teaching Hospitals NHS Foundation Trust Wigan UK
8 shared publications - Jamie C. Sergeant
Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
5 shared publications - Lianne Kearsley-Fleet
Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
5 shared publications David Nuttall
Wrightington, Wigan and Leigh NHS Trust; Upper Limb Unit; Wrightington Hospital, Hall Lane Appley Bridge Wigan Lancashire UK WN6 9EP
4 shared publications- Adrian Sayers
Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, United Kingdom
2 shared publications Alistair R Phillips
Plymouth Hospitals NHS Trust; Department of Orthopaedics; Derriford Hospital Derriford Plymouth Devon UK PL6 8DH
2 shared publications
Latest Publications
- Open Access
- 7 May 2026
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 7 (5) , 613-618
Prognostic factor research: why it matters in orthopaedics and how we do it better
By studying and predicting health outcomes, prognosis research can inform joint decision-making between a patient and clinician, and help to improve future health and care. The scope of prognosis research is broad. It can describe the natural history of a condition; identify prognostic factors (variables associated with future outcomes); develop and validate prediction models for estimating an individual’s outcome risk; and identify intervention effects that vary by specified individual characteristics. Research on prognostic factors enables personalized treatment, as it helps identify patient risk profiles that guide clinical decisions, trial design, and resource allocation, and it is a stepping stone into developing prognostic models for individualized risk predictions. However, it is imperative for prognosis research to have high standards of study design, analysis, and reporting. Inadequately executed research can lead to misleading prognostic information, resulting in inappropriate treatment or advice for some patients. A better understanding of the fundamentals of modern prognosis research methods can empower clinicians to more accurately appraise research findings in this field. This will lead to the identification and implementation of high-quality prognostic research findings, to improve healthcare and patient outcomes. However, prognostic research in orthopaedics often exhibits poor methodology, inconsistent reporting, and over-reliance on statistical significance. Recent advances in methodological guidance have provided important recommendations for study design, analysis, and reporting. Accurate interpretation requires adjusted analyses that consider known prognostic factors to prevent misleading conclusions. Key components include study registration, sample size planning, clear protocols and transparent reporting. Following these principles can greatly enhance the quality and clinical relevance of trauma and orthopaedic research. This overview introduces types of prognosis studies and then focuses on prognostic factor research and its importance within the field of Trauma and Orthopaedics (T&O). It outlines the latest advances, identifies current limitations, and directs readers towards best practices that should be adopted by researchers. Cite this article: Bone Jt Open 2026;7(5):613–618.
- 7 May 2026
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 7 (5) , 613-618
Open AccessPrognostic factor research: why it matters in orthopaedics and how we do it better
By studying and predicting health outcomes, prognosis research can inform joint decision-making between a patient and clinician, and help to improve future health and care. The scope of prognosis research is broad. It can describe the natural history of a condition; identify prognostic factors (variables associated with future outcomes); develop and validate prediction models for estimating an individual’s outcome risk; and identify intervention effects that vary by specified individual characteristics. Research on prognostic factors enables personalized treatment, as it helps identify patient risk profiles that guide clinical decisions, trial design, and resource allocation, and it is a stepping stone into developing prognostic models for individualized risk predictions. However, it is imperative for prognosis research to have high standards of study design, analysis, and reporting. Inadequately executed research can lead to misleading prognostic information, resulting in inappropriate treatment or advice for some patients. A better understanding of the fundamentals of modern prognosis research methods can empower clinicians to more accurately appraise research findings in this field. This will lead to the identification and implementation of high-quality prognostic research findings, to improve healthcare and patient outcomes. However, prognostic research in orthopaedics often exhibits poor methodology, inconsistent reporting, and over-reliance on statistical significance. Recent advances in methodological guidance have provided important recommendations for study design, analysis, and reporting. Accurate interpretation requires adjusted analyses that consider known prognostic factors to prevent misleading conclusions. Key components include study registration, sample size planning, clear protocols and transparent reporting. Following these principles can greatly enhance the quality and clinical relevance of trauma and orthopaedic research. This overview introduces types of prognosis studies and then focuses on prognostic factor research and its importance within the field of Trauma and Orthopaedics (T&O). It outlines the latest advances, identifies current limitations, and directs readers towards best practices that should be adopted by researchers. Cite this article: Bone Jt Open 2026;7(5):613–618.
- Open Access
- 27 January 2026
- Published by Elsevier in JSES International
- Vol. 10 (3) , 101640
Pain score distribution: an expert elicitation study for distal humerus hemiarthroplasty and total elbow arthroplasty using a validated numerical patient rated outcome-measure in trauma
- 27 January 2026
- Published by Elsevier in JSES International
- Vol. 10 (3) , 101640
Open AccessPain score distribution: an expert elicitation study for distal humerus hemiarthroplasty and total elbow arthroplasty using a validated numerical patient rated outcome-measure in trauma
- Open Access
- 30 August 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-12
Patient and healthcare professional perspectives on which potential prognostic factors for failure of total elbow replacement should be investigated
Background: Total elbow replacement (TER) is an established treatment for the painful arthritic elbow; however, TER has higher failure rates than other joint replacements, such as hip and knee replacement. Understanding the prognostic factors associated with failure of TER is essential for informed decision-making between patients and clinicians, patient selection, and service planning. The aim of this study is to explore the views of patients and healthcare professionals on which potential prognostic factors should be investigated in relation to TER failure. Methods: This evaluation comprised of two Patient and Public Involvement (PPI) workshops and a survey. PPI workshop 1 consisted of five PPI participants who helped to develop a survey assessing the importance of potential prognostic factors to investigate. The survey was shared electronically with members of the British Elbow and Shoulder Society (BESS) and clinicians internationally. In PPI workshop 2, 15 PPI participants listed factors they thought important to investigate, and 12 completed the survey. Results: Patients and healthcare professionals agreed that most factors in the survey should be investigated. Although this is not a comparative study, more of the healthcare professionals disagreed that ethnicity (49% v 33%) and VTE prophylaxis (42% v none) were important enough to be investigated, whilst more of the patients disagreed that socioeconomic status is important to be investigated (54% v 17%). Patients and healthcare professionals also suggested other factors not listed in the survey. Conclusions: Patients and healthcare professionals agreed on the importance of investigating most prognostic factors, but some factors were favoured by only one group. The results of this evaluation could help researchers decide which prognostic factors to investigate and which to routinely collect.
- 30 August 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-12
Open AccessPatient and healthcare professional perspectives on which potential prognostic factors for failure of total elbow replacement should be investigated
Background: Total elbow replacement (TER) is an established treatment for the painful arthritic elbow; however, TER has higher failure rates than other joint replacements, such as hip and knee replacement. Understanding the prognostic factors associated with failure of TER is essential for informed decision-making between patients and clinicians, patient selection, and service planning. The aim of this study is to explore the views of patients and healthcare professionals on which potential prognostic factors should be investigated in relation to TER failure. Methods: This evaluation comprised of two Patient and Public Involvement (PPI) workshops and a survey. PPI workshop 1 consisted of five PPI participants who helped to develop a survey assessing the importance of potential prognostic factors to investigate. The survey was shared electronically with members of the British Elbow and Shoulder Society (BESS) and clinicians internationally. In PPI workshop 2, 15 PPI participants listed factors they thought important to investigate, and 12 completed the survey. Results: Patients and healthcare professionals agreed that most factors in the survey should be investigated. Although this is not a comparative study, more of the healthcare professionals disagreed that ethnicity (49% v 33%) and VTE prophylaxis (42% v none) were important enough to be investigated, whilst more of the patients disagreed that socioeconomic status is important to be investigated (54% v 17%). Patients and healthcare professionals also suggested other factors not listed in the survey. Conclusions: Patients and healthcare professionals agreed on the importance of investigating most prognostic factors, but some factors were favoured by only one group. The results of this evaluation could help researchers decide which prognostic factors to investigate and which to routinely collect.
- 7 August 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (4) , 849-855
Achilles allograft interposition arthroplasty for the treatment of proximal radio-ulnar stump impingement pain
Background: Proximal radio-ulnar stump impingement (PRUSI) describes a painful condition occurring following radial head loss. Pain occurs due to the proximal radial stump impinging against the ulna. This study aimed to evaluate the safety of a novel interposition arthroplasty method. Methods: A retrospective observational consecutive case series study was undertaken from case note review of patients with PRUSI, treated by Achilles allograft interposition arthroplasty. The technique utilised donor Achilles tendons to cushion the proximal radio-ulnar stump articulation. The primary outcome was a change in pain levels. Secondary outcomes included changes in: elbow and forearm range of movement, Mayo Elbow Performance Score (MEPS), patient satisfaction on an 11-point numerical rating scale (NRS) and adverse events. Results: From baseline to six months post intervention, the mean NRS pain score was reduced from 9/10 to 2/10 with a mean difference in NRS pain scores of −7 (95% CI −4, −10; p = 0.004). Mean MEPS increased from 56/100 (s.d. 8) to 91 (s.d. 8), with a mean difference of 35/100 (95% CI 18, 52; p = 0.005). Conclusion: Achilles tendon allograft arthroplasty represents a safe procedure for treating PRUSI. This IDEAL phase 1 study shows promising results, indicating the need for further trials.
- 7 August 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (4) , 849-855
Achilles allograft interposition arthroplasty for the treatment of proximal radio-ulnar stump impingement pain
Background: Proximal radio-ulnar stump impingement (PRUSI) describes a painful condition occurring following radial head loss. Pain occurs due to the proximal radial stump impinging against the ulna. This study aimed to evaluate the safety of a novel interposition arthroplasty method. Methods: A retrospective observational consecutive case series study was undertaken from case note review of patients with PRUSI, treated by Achilles allograft interposition arthroplasty. The technique utilised donor Achilles tendons to cushion the proximal radio-ulnar stump articulation. The primary outcome was a change in pain levels. Secondary outcomes included changes in: elbow and forearm range of movement, Mayo Elbow Performance Score (MEPS), patient satisfaction on an 11-point numerical rating scale (NRS) and adverse events. Results: From baseline to six months post intervention, the mean NRS pain score was reduced from 9/10 to 2/10 with a mean difference in NRS pain scores of −7 (95% CI −4, −10; p = 0.004). Mean MEPS increased from 56/100 (s.d. 8) to 91 (s.d. 8), with a mean difference of 35/100 (95% CI 18, 52; p = 0.005). Conclusion: Achilles tendon allograft arthroplasty represents a safe procedure for treating PRUSI. This IDEAL phase 1 study shows promising results, indicating the need for further trials.
- 6 May 2025
- Published by Springer Nature
- p. 159-174
Open Management of the Post-traumatic Stiff Elbow
- 25 March 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (2) , 354-365
A systematic review, and meta-analysis of pain outcomes following total elbow replacement and hemi-replacement for unreconstructible acute distal humerus fractures in adults
Background: Unreconstructible distal humerus fractures have been managed with total elbow replacement (TER), but there is increasing use of hemi-replacement (DHH). Pain has been identified as the most important outcome by patients. This study aims to systematically review the literature on reported pain outcomes in adult distal humerus fractures treated with TER or DHH. Methods: Medline, Embase and Central were searched using OVID, from January 2000 to September 2023, for studies in adults undergoing DHH or TER for acute closed distal humerus fractures. The primary outcome was patient-rated pain measured on a numerical rating scale. A quantitative summary of reported outcomes was stratified by intervention type. Results: Twenty-three studies met the inclusion criteria, including one published randomised controlled trial. Meta-analysis found a pooled average NRS pain for TER of 1.7/10 (95% CI: 0.44–2.99) and 1.5/10 for DHH (95% CI: 0.001–3.56). On a 4-point Likert scale the pooled probability of no pain, mild pain, moderate pain, severe pain for TER was 0.75, 0.21, 0.02, 0.00 and for DHH was 0.76, 0.11, 0.12, and 0.00. Discussion: The available evidence does not enable comparison of pain outcomes between the interventions, which should be assessed in an appropriately powered randomised trial.
- 25 March 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (2) , 354-365
A systematic review, and meta-analysis of pain outcomes following total elbow replacement and hemi-replacement for unreconstructible acute distal humerus fractures in adults
Background: Unreconstructible distal humerus fractures have been managed with total elbow replacement (TER), but there is increasing use of hemi-replacement (DHH). Pain has been identified as the most important outcome by patients. This study aims to systematically review the literature on reported pain outcomes in adult distal humerus fractures treated with TER or DHH. Methods: Medline, Embase and Central were searched using OVID, from January 2000 to September 2023, for studies in adults undergoing DHH or TER for acute closed distal humerus fractures. The primary outcome was patient-rated pain measured on a numerical rating scale. A quantitative summary of reported outcomes was stratified by intervention type. Results: Twenty-three studies met the inclusion criteria, including one published randomised controlled trial. Meta-analysis found a pooled average NRS pain for TER of 1.7/10 (95% CI: 0.44–2.99) and 1.5/10 for DHH (95% CI: 0.001–3.56). On a 4-point Likert scale the pooled probability of no pain, mild pain, moderate pain, severe pain for TER was 0.75, 0.21, 0.02, 0.00 and for DHH was 0.76, 0.11, 0.12, and 0.00. Discussion: The available evidence does not enable comparison of pain outcomes between the interventions, which should be assessed in an appropriately powered randomised trial.
- 14 March 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 17 (6) , 697-702
Anatomic or reverse shoulder arthroplasty for cuff intact glenohumeral osteoarthritis
Glenohumeral osteoarthritis in the presence of an intact rotator cuff is a debilitating condition that often leads to surgical intervention in the form of joint arthroplasty. Historically, anatomic total shoulder replacement (ATSR) had been considered the treatment of choice. Over the past decade, however, there has been a shift in treatment patterns to the use of reverse shoulder replacement to treat this condition due to concerns of subsequent rotator cuff failure and glenoid component loosening with ATSR. With continued innovation of implants and surgical techniques, it is unclear which procedure provides the best outcomes for patients. The Reverse or Anatomical replacement for Painful Shoulder Osteoarthritis, Differences between Interventions trial aims to definitively answer this question and evaluate the cost effectiveness of both procedures.
- 14 March 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 17 (6) , 697-702
Anatomic or reverse shoulder arthroplasty for cuff intact glenohumeral osteoarthritis
Glenohumeral osteoarthritis in the presence of an intact rotator cuff is a debilitating condition that often leads to surgical intervention in the form of joint arthroplasty. Historically, anatomic total shoulder replacement (ATSR) had been considered the treatment of choice. Over the past decade, however, there has been a shift in treatment patterns to the use of reverse shoulder replacement to treat this condition due to concerns of subsequent rotator cuff failure and glenoid component loosening with ATSR. With continued innovation of implants and surgical techniques, it is unclear which procedure provides the best outcomes for patients. The Reverse or Anatomical replacement for Painful Shoulder Osteoarthritis, Differences between Interventions trial aims to definitively answer this question and evaluate the cost effectiveness of both procedures.
- 1 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (11) , 1199-1202
Shoulder and elbow arthroplasty: changing practice
Shoulder and elbow arthroplasty: changing practice
- 1 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (11) , 1199-1202
Shoulder and elbow arthroplasty: changing practice
Shoulder and elbow arthroplasty: changing practice
- 1 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (11) , 1306-1311
Core Outcome Domains for Elbow Replacement (CODER)
Aims: A review of the literature on elbow replacement found no consistency in the clinical outcome measures which are used to assess the effectiveness of interventions. The aim of this study was to define core outcome domains for elbow replacement.Methods: A real-time Delphi survey was conducted over four weeks using outcomes from a scoping review of 362 studies on elbow replacement published between January 1990 and February 2021. A total of 583 outcome descriptors were rationalized to 139 unique outcomes. The survey consisted of 139 outcomes divided into 18 domains. The readability and clarity of the survey was determined by an advisory group including a patient representative. Participants were able to view aggregated responses from other participants in real time and to revisit their responses as many times as they wished during the study period. Participants were able to propose additional items for inclusion. A Patient and Public Inclusion and Engagement (PPIE) panel considered the consensus findings.Results: A total of 45 respondents completed the survey. Nine core mandatory domains were identified: ‘return to work or normal daily role’; delivery of care was measured in the domains ‘patient satisfaction with the outcome of surgery’ and ‘would the patient have the same operation again’; ‘pain’; ‘revision’; ‘elbow function’; ‘independence in activities of daily living’; ‘health-related quality of life’; and ‘adverse events’. ‘Elbow range of motion’ was identified as important by consensus but was felt to be less relevant by the PPIE panel. The PPIE panel unanimously stated that pain should be used as the primary outcome domain.Conclusion: This study defined core domains for the clinical outcomes of elbow replacement obtained by consensus from patients, carers, and healthcare professionals. Pain may be used as the primary outcome in future studies, where appropriate. Further work is required to define the instruments that should be used.Cite this article: Bone Joint J 2024;106-B(11):xxx–xxx.
- 1 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (11) , 1306-1311
Core Outcome Domains for Elbow Replacement (CODER)
Aims: A review of the literature on elbow replacement found no consistency in the clinical outcome measures which are used to assess the effectiveness of interventions. The aim of this study was to define core outcome domains for elbow replacement.Methods: A real-time Delphi survey was conducted over four weeks using outcomes from a scoping review of 362 studies on elbow replacement published between January 1990 and February 2021. A total of 583 outcome descriptors were rationalized to 139 unique outcomes. The survey consisted of 139 outcomes divided into 18 domains. The readability and clarity of the survey was determined by an advisory group including a patient representative. Participants were able to view aggregated responses from other participants in real time and to revisit their responses as many times as they wished during the study period. Participants were able to propose additional items for inclusion. A Patient and Public Inclusion and Engagement (PPIE) panel considered the consensus findings.Results: A total of 45 respondents completed the survey. Nine core mandatory domains were identified: ‘return to work or normal daily role’; delivery of care was measured in the domains ‘patient satisfaction with the outcome of surgery’ and ‘would the patient have the same operation again’; ‘pain’; ‘revision’; ‘elbow function’; ‘independence in activities of daily living’; ‘health-related quality of life’; and ‘adverse events’. ‘Elbow range of motion’ was identified as important by consensus but was felt to be less relevant by the PPIE panel. The PPIE panel unanimously stated that pain should be used as the primary outcome domain.Conclusion: This study defined core domains for the clinical outcomes of elbow replacement obtained by consensus from patients, carers, and healthcare professionals. Pain may be used as the primary outcome in future studies, where appropriate. Further work is required to define the instruments that should be used.Cite this article: Bone Joint J 2024;106-B(11):xxx–xxx.
- Open Access
- 1 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (11) , 1312-1320
Total elbow arthroplasty in England
Aims: The aim of this study was to review the provision of total elbow arthroplasties (TEAs) in England, including the incidence, the characteristics of the patients and the service providers, the types of implant, and the outcomes.Methods: We analyzed the primary TEAs recorded in the National Joint Registry (NJR) between April 2012 and December 2022, with mortality data from the Civil Registration of Deaths dataset. Linkage with Hospital Episode Statistics-Admitted Patient Care (HES-APC) data provided further information not collected by the NJR. The incidences were calculated using estimations of the populations from the Office for National Statistics. The annual number of TEAs performed by surgeons and hospitals was analyzed on a national and regional basis.Results: A total of 3,891 primary TEAs were included. The annual incidence of TEA was between 0.72 and 0.82 per 100,000 persons before 2020 and declined to 0.4 due to a decrease in elective TEAs during the COVID-19 pandemic, with a slight recovery in 2022. Older patients, those of white ethnicity and females, were more likely to undergo TEA. Those who underwent elective TEA had a median wait of between 89 (IQR 41 to 221) and 122 days (IQR 74 to 189) in the years before 2021, and this increased to 183 days (IQR 66 to 350) in 2021. The number of TEAs performed by surgeons per annum remained unchanged, with a median of two (IQR 1 to 3). The median annual number of TEAs per region was three to six times higher than the median annual case load of the highest volume hospital in a region. Patients in the lowest socioeconomic group had a higher rate of serious adverse events and mortality (11%) when undergoing TEA for acute trauma.Conclusion: In England, TEA is more common in older age groups, those of white ethnicity, and females. The COVID-19 pandemic affected the incidence of elective TEA and waiting times, and the provision of TEA has not yet recovered. The Getting it Right First Time recommendation of centralizing services to one centre per region could result in up to a six-fold increase in the number of TEAs being performed in some centres.Cite this article: Bone Joint J 2024;106-B(11):1312–1320.
- 1 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (11) , 1312-1320
Open AccessTotal elbow arthroplasty in England
Aims: The aim of this study was to review the provision of total elbow arthroplasties (TEAs) in England, including the incidence, the characteristics of the patients and the service providers, the types of implant, and the outcomes.Methods: We analyzed the primary TEAs recorded in the National Joint Registry (NJR) between April 2012 and December 2022, with mortality data from the Civil Registration of Deaths dataset. Linkage with Hospital Episode Statistics-Admitted Patient Care (HES-APC) data provided further information not collected by the NJR. The incidences were calculated using estimations of the populations from the Office for National Statistics. The annual number of TEAs performed by surgeons and hospitals was analyzed on a national and regional basis.Results: A total of 3,891 primary TEAs were included. The annual incidence of TEA was between 0.72 and 0.82 per 100,000 persons before 2020 and declined to 0.4 due to a decrease in elective TEAs during the COVID-19 pandemic, with a slight recovery in 2022. Older patients, those of white ethnicity and females, were more likely to undergo TEA. Those who underwent elective TEA had a median wait of between 89 (IQR 41 to 221) and 122 days (IQR 74 to 189) in the years before 2021, and this increased to 183 days (IQR 66 to 350) in 2021. The number of TEAs performed by surgeons per annum remained unchanged, with a median of two (IQR 1 to 3). The median annual number of TEAs per region was three to six times higher than the median annual case load of the highest volume hospital in a region. Patients in the lowest socioeconomic group had a higher rate of serious adverse events and mortality (11%) when undergoing TEA for acute trauma.Conclusion: In England, TEA is more common in older age groups, those of white ethnicity, and females. The COVID-19 pandemic affected the incidence of elective TEA and waiting times, and the provision of TEA has not yet recovered. The Getting it Right First Time recommendation of centralizing services to one centre per region could result in up to a six-fold increase in the number of TEAs being performed in some centres.Cite this article: Bone Joint J 2024;106-B(11):1312–1320.